Navigation Links
CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
Date:10/10/2008

CORPUS CHRISTI, Texas, Oct. 10 /PRNewswire-FirstCall/ -- CSMG Technologies, Inc., (OTC Bulletin Board: CTGI), a technology management company, announced the company has received approval of its fifth U.S. patent. The approval is on a key divisional application for "Bonding of Soft Biological Tissues by Passing High Frequency Electric Current Therethrough" for CSMG Technologies subsidiary Live Tissue Connects ("LTC") platform tissue bonding/welding technology. The patent approval follows the issuance of four other U.S. patents, a European Union patent, in eight European countries, Ukraine, Canada and Australia with 14 U.S. and international patents pending.

Donald S. Robbins, President and CEO of CSMG Technologies, said, "This key U.S. patent approval re-enforces our patent portfolio and expands LTC's commercial possibilities while increasing our shareholder value. Our strong patent portfolio, and a disruptive technology as well as ISO 13485:2003 certification for the design and manufacture of Bipolar Forceps Systems, recent US FDA 510(k) clearance and European Union C. E. Mark certification on LTC's VAD.400 electrosurgery generator and two instruments puts us in an excellent position of competing in global medical device markets."

"Our LTC team has presented comparative results at conferences with the LTC bipolar sealing system and shown that LTC's bipolar sealing system has broad applications. Additionally, in preparation for launching LTC's commercial product I early 2009, LTC has begun building inventory for both LTC's electro surgery generator and hand instrument for duct and vessel sealing, and are in discussions with interested international medical device companies and distributors," Mr. Robbins added.

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as
'/>"/>

SOURCE CSMG Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Baylor Research Institute (BRI) at ... Institute (TGen) in Phoenix, AZ , ... detection and treatments for patients with a broad range of ... to new clinical trials and access to technology to drive ... bench to bedside across Baylor Scott & White ...
(Date:5/21/2015)... Seventh Wave Laboratories, a consulting-based contract ... pharmaceutical products and medical devices, announced the purchase of ... 50,000 sq. ft. building more than three times the ... Facility renovations will begin immediately and the gradual transition ... in September. , “We are excited about this ...
(Date:5/21/2015)... , May 21, 2015  Susan Hedstrom, Executive ... a nonprofit organization dedicated to supporting research to ... (PWS), announced today that FPWR has received the ... Irina Shaulov contributed $1 million in support ... "Our gift ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
Breaking Biology Technology:Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3
... Contaminations of cell cultures show severe problems in the research ... turns here particularly to the prevention , ... that develop substances for therapeutic applications ... focus., Endotoxins (Lipopolysaccharides, LPS) are biologically active, ...
... Amino Acids, RP-HPLC, Precolumn derivatisation, o-Phthalaldehyde (OPA), 2-Mercaptopropionic acid, ... Introduction: , ... light in the UV/visible spectrum. In order to increase sensitivity, ... the amino acids react with a precursor to yield ...
... and specific PCR on any thermal cycler , ... unrivaled performance of , HotStarTaq Plus DNA Polymerase with ... thermal cycler. , , ... Ultrafast hot-start PCR time savings of up to 75%, ...
Cached Biology Technology:Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 2Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 3Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 4Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 5Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 6Endotoxins and their Relevance in R&D ApplicationsLPS Detection & Removal Methods 7ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 2ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 3QIAGEN Fast Cycling PCR Kit 2QIAGEN Fast Cycling PCR Kit 3QIAGEN Fast Cycling PCR Kit 4
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/8/2015)... SAN JOSE, Calif. , May 8, 2015 ... human interface solutions, today announced that members of the executive ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Westin Waterfront Hotel in Boston, MA ... Date: May 27, 2015 Time: 2:45pm ET Location: The New ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... For Immediate Release The Scripps Research Institute and ... Medicine have been awarded approximately $7.5 million over five ... drug candidates for the treatment of nicotine dependence, and ... million will go to Scripps Research, $2.5 million to ...
... of Guelph researchers have finally figured out why female ... nothing to do with genes and everything to do ... "Their behaviour is overwhelmingly influenced by opportunity," said ... professor Andrew McAdam and a team of researchers from ...
... what goes missing in human cells when the gene that ... Johns Hopkins scientists have discovered a potential strategy for therapy. ... snippets known as microRNAs is dramatically reduced in human pancreatic ... a study published Dec. 15 in Genes and Development ...
Cached Biology News:Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 2Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 3Opportunity leads to promiscuity among squirrels, study finds 2Missing molecules hold promise of therapy for pancreatic cancer 2Missing molecules hold promise of therapy for pancreatic cancer 3
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
...
...
Recombinant Rat Fas Ligand/TNFSF6...
Biology Products: